Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Aug:129:104519.
doi: 10.1016/j.jcv.2020.104519. Epub 2020 Jun 23.

Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits

Allen Wing-Ho Chu  1 , Wan-Mui Chan  1 , Jonathan Daniel Ip  1 , Cyril Chik-Yan Yip  2 , Jasper Fuk-Woo Chan  3 , Kwok-Yung Yuen  3 , Kelvin Kai-Wang To  4
Affiliations
Comparative Study

Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits

Allen Wing-Ho Chu et al. J Clin Virol. 2020 Aug.

Abstract

Background: The severe shortage of nucleic acid extraction kits during the current COVID-19 pandemic represents a key limiting factor in testing capacity.

Objectives: This study compared the results of SARS-CoV-2 RT-PCR using different simple nucleic acid extraction methods on nasopharyngeal and saliva specimens.

Study design: Fifty nasopharyngeal swab and saliva specimens previously tested positive for SARS-CoV-2 were retrieved. Three different methods of nucleic acid extraction were compared. The first method involves incubating the specimen with proteinase K, and then heat treatment at 98 °C for 5 min (PKH); the second method involves heat treatment at 98 °C for 5 min without proteinase K pre-incubation (heat only); the third method involves no pre-processing steps (direct). The products from all 3 methods were tested by SARS-CoV-2 RT-PCR.

Results: PKH had significantly higher positive rate in SARS-CoV-2 RT-PCR (80 %) than those of heat only (58 %; P = 0.001) or direct (56 %; P = 0.002). The median Ct value was significantly earlier for PKH (median Ct: 37.0, IQR 31.7-40) than that of heat only (median Ct: 40, IQR 36.2-41; P < 0.0001) and direct (median Ct, 37.5; IQR 33.9-41.0; P = 0.0049). Subgroup analysis showed that PKH had higher detection rate, lower limit of detection and earlier Ct values than the other two groups for both NPS and saliva specimens.

Conclusions: PKH pre-processing resulted in the highest detection rate of SARS-CoV-2 by RT-PCR, and represents an alternative method for nucleic acid extraction when commercial extraction kits are not available.

Keywords: COVID-19; Detection; Nucleic acid extraction; Proteinase K; RT-PCR; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

Figures

Fig. 1
Fig. 1
Comparison of RT-PCR results from different nucleic acid extraction methods. The Ct values were compared between the PKH, heat only and direct groups. PKH: specimens pre-incubated with proteinase K for 15 min at 56 °C, followed by 5 min at 98 °C. Heat only: specimens were heated for 5 min at 98 °C. Direct: no pre-processing step before RT-PCR. Original: Total nucleic acid was extracted using NucliSENS easyMAG extraction system. *, <0.05; ****, <0.0001.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 doi: 10.1016/S0140-6736(20)30154-30159. - DOI - PMC - PubMed
    1. Cheng V.C.C., Wong S.C., To K.K.W., Ho P.L., Yuen K.Y. Preparedness and proactive infection control measures against the emerging novel coronavirus in China. J. Hosp. Infect. 2020;104:254–255. - PMC - PubMed
    1. Peto J. Covid-19 mass testing facilities could end the epidemic rapidly. BMJ. 2020;368:m1163. - PubMed
    1. Hung I.F., Lung K.C., Tso E.Y., Liu R., Chung T.W., Chu M.Y. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 doi: 10.1016/S0140-6736(20)31042-31044. - DOI - PMC - PubMed
    1. Fomsgaard A.S., Rosenstierne M.W. 2020. An Alternative Workflow for Molecular Detection of SARS-CoV-2 - Escape From the NA Extraction Kit-shortage; p. 25. Copenhagen, Denmark, March 2020. Euro Surveill. - PMC - PubMed

Publication types